When did the Agency begin looking into PFOA and its potential risks?
In the late 1990’s, EPA received information indicating that PFOS was widespread in the blood of the general population, and presented concerns for persistence, bioaccumulation, and toxicity. Following discussions between EPA and 3M, the manufacturer of PFOS and PFOS-related chemicals, the company terminated production of these chemicals. Findings on PFOS led EPA to review similar chemicals, including PFOA, to determine whether they might present concerns similar to those associated with PFOS.
Related Questions
- What if the agency or its IPA can’t do an objective internal review of the matter because of a potential conflict of interest?
- Why do I have to disclose potential sources of funding and agency submission dates on my HSIRB application?
- WHAT ARE YOU LOOKING FOR IN POTENTIAL CLIENTS FOR THE KIM DAWSON AGENCY?
